DISCLOSURES

Modern Slavery

Each year, the Board approves CSL’s Statement on the Prevention of Human Trafficking, Slavery and Forced Labour. The Statement details the steps the CSL Group is currently undertaking to address and prevent modern slavery. CSL published its first statement in 2016.


Tax Transparency

Seqirus is guided in tax matters by a CSL board-approved tax philosophy which among other things, commits the company to publishing an annual Tax Transparency Report. Our first report was published in 2018. 


Australian Packaging Covenant

Seqirus's Australian operations are also a signatory to the Australian Packaging Covenant (APC). As part of our commitment to the goals and principles of the APC, an action plan has been developed with actions that will integrate the principles sustainable packaging and product stewardship into packaging design process. Access to additional information can be found on the APC website - www.packagingcovenant.org.au.


Medicines Australia Code of Conduct

In Australia, Seqirus is a member of Medicines Australia (MA) and complies with the MA Code of Conduct. We have prepared the following reportable transfers of payment report for publication in accordance with Edition 18 of the MA Code of Conduct, and in a manner consistent with Australia’s Privacy legislation.

Seqirus Health Consumer Organisations support (as published by Medicines Australia)

SEQ/CORP/1019/0027 October 2019

Corporate Responsibility

We conduct our business ethically and contribute to the economic, social and environmental well-being of our communities.

Learn more
Innovation

Innovation is vital to achieving our vision of world protected from influenza.

Learn more
Career Opportunities

Join us in helping protect the world from influenza with the brightest, most passionate people from every discipline.

Learn more